AXT, Inc. 10-Q Filing Summary
Business Context and Reporting Period
Company: AXT, Inc. (AXTI)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2026
Business Overview: AXT develops and produces high-performance compound and single-element semiconductor substrate wafers (Indium Phosphide, Gallium Arsenide, Germanium) and raw materials. Manufacturing is conducted primarily in China through consolidated subsidiaries and joint ventures.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2026 |
Six Months Ended June 30, 2026 |
Six Months Ended June 30, 2025 |
|---|---|---|---|
| Revenue | $47,589 | $74,513 | $37,330 |
| Gross Profit | $21,366 | $29,344 | $192 |
| Gross Margin | 44.9% | 39.4% | 0.5% |
| Net Income (Loss) Attributable to AXT | $11,128 | $9,508 | $(15,806) |
| Diluted EPS | $0.17 | $0.16 | $(0.36) |
| Cash and Cash Equivalents | $412,167 (as of June 30, 2026) | ||
| Total Investments | $303,631 (as of June 30, 2026) | ||
| Short-term Loans | $84,233 (as of June 30, 2026) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 164.8% year-over-year for the quarter and 99.6% for the six-month period. This was driven by higher demand for Indium Phosphide (InP) wafers for data center applications and raw materials, following the receipt of export permits from Chinese authorities.
- Profitability Turnaround: The company returned to profitability, reporting net income of $11.1 million for the quarter compared to a loss of $7.0 million in the prior year quarter. Gross margin expanded significantly from 8.0% to 44.9% (quarterly) due to higher volume spreading fixed costs and favorable product mix.
- Liquidity Expansion: Cash and restricted cash increased by $316.9 million in the first half of 2026. This surge was primarily funded by a secondary public offering in April 2026 (gross proceeds ~$632.5 million) and a December 2025 offering (~$100 million).
- Interest Income: Net interest income turned positive ($4.7 million for the quarter) due to the investment of proceeds from recent capital raises.
Guidance, Outlook, and Material Events
- IPO Withdrawal and Redemption Rights: On July 8, 2026, the Shanghai Stock Exchange STAR Market accepted the withdrawal of Tongmei's IPO application. This triggers redemption rights for private equity investors, potentially requiring the company to repay approximately $49 million. Management states it has sufficient funds to cover full redemption if required.
- Strategic Pivot: The company is shifting focus from the STAR Market to a potential listing on the Hong Kong Stock Exchange, emphasizing its InP business for AI and data center applications.
- Long-Term Supply Agreements: The company entered into significant capacity reservation agreements with major customers (Casela, Coherent, Lumentum) involving substantial prepayments (e.g., $87 million total deposits from Lumentum), securing future revenue visibility.
- Trade and Export Risks: While export permits for InP to Europe and Japan have been received, the company faces ongoing uncertainty regarding permits for U.S. exports due to Chinese export controls and U.S. tariffs. The U.S. Supreme Court invalidated certain IEEPA tariffs in February 2026, but Section 301 and 232 tariffs remain.
- Legal Proceedings: A putative shareholder class action and a derivative lawsuit remain pending. The company intends to vigorously defend against these claims, which it deems meritless.
Investor Verification Checklist
- Redemption Obligation: Verify the status of negotiations with private equity investors regarding the $49 million redemption right triggered by the STAR Market IPO withdrawal.
- Export Permit Stability: Monitor the approval status of Indium Phosphide export permits for the U.S. market, as this remains a critical bottleneck for revenue recognition in North America.
- Capital Deployment: Assess the utilization of the ~$750 million in cash and investments, specifically regarding the ramp-up of InP manufacturing capacity and the funding of new supply agreements.
- Customer Concentration: Review the terms of the new long-term supply agreements to understand the risk of customer demand shifts or failure to meet capacity commitments.
- Legal Exposure: Track the progress of the shareholder class action and derivative lawsuit for potential settlement costs or reputational impact.